Cambridge Investment Research Advisors, Inc. - MADRIGAL PHARMACEUTICALS INC ownership

MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 91 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of MADRIGAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,024
-37.3%
7,014
-0.8%
0.01%
-28.6%
Q2 2023$1,633
+1.8%
7,068
+6.8%
0.01%
-12.5%
Q1 2023$1,604
-56.0%
6,620
-47.3%
0.01%
-57.9%
Q4 2022$3,646
-99.3%
12,560
+60.0%
0.02%
+533.3%
Q3 2022$510,000
-8.1%
7,850
+1.3%
0.00%0.0%
Q2 2022$555,000
-32.2%
7,750
-7.2%
0.00%
-25.0%
Q1 2022$819,000
+31.5%
8,350
+13.6%
0.00%
+33.3%
Q4 2021$623,000
-6.5%
7,350
-12.0%
0.00%0.0%
Q3 2021$666,000
-18.1%
8,3500.0%0.00%
-25.0%
Q2 2021$813,000
-59.3%
8,350
-51.1%
0.00%
-63.6%
Q1 2021$1,996,000
+11.8%
17,060
+6.2%
0.01%
+10.0%
Q4 2020$1,785,000
-4.0%
16,060
+2.6%
0.01%
-23.1%
Q3 2020$1,859,000
+5.5%
15,660
+0.6%
0.01%0.0%
Q2 2020$1,762,000
+77.6%
15,560
+4.7%
0.01%
+30.0%
Q1 2020$992,000
-26.5%
14,860
+0.3%
0.01%0.0%
Q4 2019$1,349,000
+7.1%
14,810
+1.4%
0.01%
-9.1%
Q3 2019$1,259,000
-18.3%
14,600
-0.7%
0.01%
-21.4%
Q2 2019$1,541,000
-14.6%
14,700
+2.1%
0.01%
-17.6%
Q1 2019$1,804,000
+26.1%
14,400
+13.4%
0.02%
+6.2%
Q4 2018$1,431,000
+234.3%
12,698
+535.5%
0.02%
+300.0%
Q3 2018$428,000
-49.1%
1,998
-33.6%
0.00%
-55.6%
Q2 2018$841,000
-35.0%
3,007
-72.9%
0.01%
-40.0%
Q1 2018$1,294,000
+60.9%
11,082
+26.6%
0.02%
+66.7%
Q4 2017$804,000
+127.8%
8,757
+11.5%
0.01%
+80.0%
Q3 2017$353,0007,8570.01%
Other shareholders
MADRIGAL PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
HealthCor Management, L.P. 1,402,250$93,614,0004.00%
Parkman Healthcare Partners LLC 30,000$2,003,0000.93%
ARMISTICE CAPITAL, LLC 216,000$14,420,0000.89%
Avoro Capital Advisors LLC 349,000$23,299,0000.79%
Rock Springs Capital Management LP 250,000$16,690,0000.69%
Capital Impact Advisors, LLC 24,351$1,626,0000.68%
Baker Brothers Advisors 1,499,212$100,087,0000.62%
EWG Elevate Inc. 11,086$740,0000.56%
SHIKIAR ASSET MANAGEMENT INC 12,000$801,0000.54%
DAFNA Capital Management LLC 13,600$908,0000.38%
View complete list of MADRIGAL PHARMACEUTICALS INC shareholders